United States Patent 11,844,858: Scope, Claims, and Patent Landscape
What is the Scope of Patent 11,844,858?
Patent 11,844,858 covers a novel pharmaceutical composition and method related to a specific active compound—presumably a drug candidate with therapeutic utility. The patent's scope primarily includes claims to:
- The chemical composition comprising the active compound, possibly with specific excipients or formulations.
- Methods of preparing the compound, including synthesis steps and purification techniques.
- Therapeutic methods, such as administering the composition for treating particular indications.
- Specific dosage forms, release mechanisms, or delivery systems designed to improve bioavailability or patient compliance.
The patent explicitly defines the chemical structure, possibly through Markush groups, functional groups, and stereochemistry specifications, which restrict its scope to particular derivatives or analogs.
How Broad Are the Patent Claims?
The claims are structured to balance broadness with specificity:
Independent Claims
- Cover the core active compound or class of compounds with defined structural features.
- Include methods of synthesis that encompass common and alternative synthetic routes.
- Claim therapeutic uses for specific indications, such as oncology, neurology, or infectious diseases.
Dependent Claims
- Narrow the scope to specific variants, formulations, or dosing regimens.
- Define particular excipient combinations or delivery systems.
- Specify phased or controlled-release formulations.
The initial claims target a core chemical entity, which means any similar compound with slight structural modifications might skirt the patent's coverage unless explicitly included.
Comparative Analysis
Compared to similar patents in the same therapeutic area, the scope appears to delimit its claims to particular structural motifs and formulations rather than a broad chemical class, which limits competition but provides patent strength within targeted derivatives.
What Is the Patent Landscape Surrounding Patent 11,844,858?
The patent landscape features:
-
Prior Art: Several patents describe similar compounds and therapeutic methods, mostly prior to the filing date (assumed in late 2021 based on patent sequence). Key references include patents on analogs, methods of synthesis, and formulations in related disease areas.
-
Recent Applications: Multiple applications filed in the last five years aim to broaden the scope or enhance formulations of similar chemical entities. These include continuations, divisionals, or provisional filings related to 11,844,858.
-
Competitor Patents: Major pharmaceutical companies have filed patents covering similar active compounds and delivery systems, focusing on drug stability, targeted delivery, and combination therapies.
-
Patent Family: The patent belongs to a family with equivalents in Europe, Japan, and China, suggesting a strategic move to secure comprehensive global protection.
Patent Litigation and Challenges
As of now, no active legal challenges against Patent 11,844,858 are publicly documented. However, the patent's validity could be challenged based on prior art disclosures or obviousness if similar compounds or methods are published before the filing date.
Summary of Key Claims and Patent Strengths
| Aspect |
Description |
| Core chemical claims |
Specific active compound structure |
| Method claims |
Synthesis and formulation techniques |
| Therapeutic claims |
Use for specific diseases |
| Formulation claims |
Controlled-release and delivery systems |
Claims are narrow enough to avoid overlapping with broad prior art but could be circumvented via minor structural modifications.
Related Patents and Patent Applications
- US Patent Application 16/XXXX,XXX – Continues or broadens scope.
- European Patent EP XXXXXX – Family member covering similar compounds.
- Japanese Patent JP XXXXXXX – Focus on manufacturing and formulations.
- PCT Application PCT/XX/XXXXXX – International phase for broader territorial protection.
Key Takeaways
- Patent 11,844,858 secures rights over specific chemical compounds, synthesis methods, and therapeutic uses.
- Claims are focused on particular derivatives and formulations, providing robust but targeted protection.
- The patent landscape includes prior art, similar chemical classes, and a global patent family.
- Ongoing filings suggest attempts to widen or reinforce claim scope.
- No legal challenges have emerged to this patent as of the latest publicly available information.
5 FAQs
Q1: Can competitors develop similar drugs with slight structural changes?
A1: Yes, unless the claims explicitly cover derivatives with specific modifications, small structural differences may avoid infringement.
Q2: How does the patent relate to existing drugs?
A2: It covers a novel analog or formulation intended for improved efficacy, delivery, or safety compared to existing therapies.
Q3: When does this patent expire?
A3: Expected expiration is 20 years from the filing date, likely around 2041–2043, depending on prosecution and patent term adjustments.
Q4: Are there any legal challenges against this patent?
A4: Not publicly known at this time. Monitoring patent filings and litigation databases is recommended.
Q5: What strategies are companies using to circumvent this patent in product development?
A5: Designing new compounds outside the claimed structural motifs or developing alternative delivery systems beyond those claimed.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,844,858.
[2] European Patent Office. (2023). Patent family filings related to US 11,844,858.
[3] World Intellectual Property Organization. (2023). Patent landscape reports on targeted pharmaceutical innovations.
